drugset / Trial / NCT01120418
Corneal Endothelial Cell Density Changes In Healthy Subjects, When Administered ISV-403 for 5 Days
RandomizedParallel-groupOpen-labelScreening
Summary
The objective of this study is to evaluate the effect on corneal endothelial cell density changes when ISV-403 is administered for five (5) days compared to no drug treatment, in healthy subjects.
Timeline
- Start
- 2007-05
- Primary completion
- 2007-10
- Completion
- 2008-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Besifloxacin | Small molecule | 0.6 % | Topical |
Indications
No indication recorded.